{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:04:47Z","timestamp":1791288287851,"version":"4.3.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,7,5]],"date-time":"2014-07-05T00:00:00Z","timestamp":1404518400000},"content-version":"vor","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Dana Farber Cancer Institute Friends of Head and Neck Cancer Research","award":["CA68051"],"award-info":[{"award-number":["CA68051"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA132279"],"award-info":[{"award-number":["CA132279"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.virol.2013.03.016","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T05:52:04Z","timestamp":1366264324000},"page":"107-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein\u2013Barr virus associated nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"441","author":[{"given":"Mark","family":"Fogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2013.03.016_bib14","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.4049\/jimmunol.165.12.7078","article-title":"The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1","volume":"165","author":"Blake","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2013.03.016_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.20454","article-title":"An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection","volume":"40","author":"Cabrera","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2013.03.016_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.177.2.339","article-title":"Epstein\u2013Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells","volume":"177","author":"Deacon","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2013.03.016_bib8","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2009-03-209650","article-title":"T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model","volume":"113","author":"Di Stasi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib12","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1073\/pnas.0813320106","article-title":"Decreased EBNA-1-specific CD8+ T cells in patients with Epstein\u2013Barr virus-associated nasopharyngeal carcinoma","volume":"106","author":"Fogg","year":"2009","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2013.03.016_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/bjc.1987.28","article-title":"Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells","volume":"55","author":"Herait","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.virol.2013.03.016_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein\u2013Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virol.2013.03.016_bib11","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2008-02-142596","article-title":"Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein\u2013Barr virus-infected nasopharyngeal carcinoma cells","volume":"113","author":"Klibi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib24","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/sj.bjc.6603580","article-title":"Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients","volume":"96","author":"Lau","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.virol.2013.03.016_bib23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.7150\/ijbs.7.607","article-title":"Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy","volume":"7","author":"Li","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.virol.2013.03.016_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1479-5876-9-189","article-title":"Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma","volume":"9","author":"Li","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virol.2013.03.016_bib7","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood-2008-05-157222","article-title":"Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients","volume":"113","author":"Louis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib26","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/ijc.22617","article-title":"Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro","volume":"120","author":"Mahnke","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2013.03.016_bib21","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.4049\/jimmunol.170.12.6183","article-title":"Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1","volume":"170","author":"Marshall","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2013.03.016_bib9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1073\/pnas.70.1.190","article-title":"Release of infectious Epstein\u2013Barr virus by transformed marmoset leukocytes","volume":"70","author":"Miller","year":"1973","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2013.03.016_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2008-01-135319","article-title":"Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines","volume":"112","author":"Morse","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ijc.2910320307","article-title":"Epstein\u2013Barr virus specific T-cell response in nasopharyngeal carcinoma patients","volume":"32","author":"Moss","year":"1983","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2013.03.016_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1096-9896(199601)178:1<44::AID-PATH471>3.0.CO;2-0","article-title":"In situ detection of the Epstein\u2013Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas","volume":"178","author":"Murray","year":"1996","journal-title":"J. Pathol."},{"key":"10.1016\/j.virol.2013.03.016_bib4","first-page":"879","article-title":"Expression of Epstein\u2013Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas","volume":"140","author":"Niedobitek","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2013.03.016_bib18","first-page":"493","article-title":"A simple method of estimating fity percent end-points","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virol.2013.03.016_bib1","first-page":"2655","article-title":"Epstein\u2013Barr Virus","volume":"vol. 2","author":"Rickinson","year":"2007"},{"key":"10.1016\/j.virol.2013.03.016_bib6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/0008-5472.CAN-11-3399","article-title":"Effective treatment of metastatic forms of Epstein\u2013Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy","volume":"72","author":"Smith","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2013.03.016_bib15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","article-title":"Treatment of nasopharyngeal carcinoma with Epstein\u2013Barr virus\u2014specific T lymphocytes","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.virol.2013.03.016_bib22","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/0008-5472.CAN-04-2552","article-title":"Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation","volume":"65","author":"Voo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2013.03.016_bib16","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1016\/S0021-9258(19)38482-0","article-title":"Structure\/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells","volume":"265","author":"Williams","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2013.03.016_bib19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Xu","year":"2006","journal-title":"J. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682213001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682213001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:19:45Z","timestamp":1758586785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682213001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0042682213001694"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2013.03.016","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein\u2013Barr virus associated nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2013.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}